CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?

One stock that's been on my watch list for a while is CRISPR Therapeutics (NASDAQ: CRSP). The company has an intriguing ...

CRISPR Therapeutics (CRSP) reports $116M FY25 revenue driven by Casgevy growth

CRISPR Therapeutics (NASDAQ:CRSP) is one of the best stocks for 20 years. On February 12, CRISPR Therapeutics announced its financial results for 2025, highlighting a period of significant commercial ...

CRISPR (CRSP) Rated Overweight on Gene Editing Growth

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the stocks that could 10x over the next 10 years. Piper Sandler boosted its ...

Here’s What Analysts Are Saying About CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the top gene therapy stocks to buy according to hedge funds. On February 17, ...
Insider Monkey

Is Crispr Therapeutics (CRSP) The Best Gene-Editing Stock to Buy Now?

Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr Therapeutics Ag (NASDAQ:CRSP) shares are up 16% over the past 12 months.

Is CRISPR Therapeutics stock a buy now?

We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.